MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

04 Nov 2025 Evaluate
Glenmark Pharmaceuticals has informed that the company has enclosed a press release titled, ‘Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial’.

The above information is a part of company’s filings submitted to BSE.  


Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..